Factors Influencing Outcomes of Revision Surgeries Following Failed TAA
Overview
This study compares survival outcomes of revision ankle arthrodesis (RAA) and revision total ankle arthroplasty (RTAA) following failed total ankle arthroplasty (TAA). It highlights the impact of patient-related and procedure-related factors on revision outcomes, emphasizing the need for tailored strategies in managing failed TAA cases.
Background
Total ankle arthroplasty (TAA) is a common treatment for end-stage ankle arthritis, with significant rates of revision surgeries due to failure. Understanding the factors influencing outcomes of revision procedures is crucial for improving patient care and optimizing surgical strategies. This study addresses the gap in literature regarding comparative outcomes of RAA and RTAA, which is essential as the number of TAA procedures increases.
Data Highlights
The study included 124 revision cases, comparing RAA and RTAA outcomes based on demographic characteristics, comorbidities, and reoperation rates.
Key Findings
Ten-year survivorship of modern TAA designs is approximately 89%, with some exceeding 90%.
Revision rates for TAA are reported at 12.6% at 7 years and 18% at 10 years.
RAA has solid union rates up to 90%, but carries risks of nonunion and adjacent joint degeneration.
RTAA outcomes vary widely, with 5-year survival rates ranging from 60% to 80%.
Patient-related factors such as elevated BMI and age significantly influence revision outcomes.
Implant-related factors, including the presence of periarticular cysts, affect the risk of failure after TAA.
Clinical Implications
Clinicians should consider patient-related factors such as BMI and age when planning revision surgeries for failed TAA. Tailoring surgical strategies based on individual risk profiles may improve outcomes for patients undergoing RAA or RTAA.
Conclusion
This study underscores the importance of understanding both patient and procedure-related factors in the management of failed TAA. Future research should continue to explore these variables to enhance surgical outcomes.
Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.
